Allogeneic Cell Therapy market Trends, Analysis by 2035

Considering the potential benefits of allogeneic cell therapies, several researchers and industry stakeholders have been continuously exploring such therapy candidates for applications across a myriad of disease indications

Roots Analysis is pleased to announce the publication of its recent study, titled, “Allogeneic Cell Therapy Market, 2023-2035.”

The research report presents an in-depth analysis, highlighting the capabilities of various stakeholders in this market, across different geographies. Amongst other elements, the market report includes:

  • A detailed assessment of the overall landscape of allogeneic cell therapies and allogeneic therapy developers based on several relevant parameters.
  • A detailed analysis of the partnerships established between stakeholders engaged in this industry, since 2019
  • An analysis of the funding and investments that have been made into companies developing allogeneic cell therapies
  • An analysis of completed and ongoing clinical trials related to allogeneic cell therapies, based on several relevant parameters
  • An insightful analysis, highlighting the key opinion leaders (KOLs) investigating clinical trials related to allogeneic cell therapies.
  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
  • Type of Cell Therapy
  • Stem Cell
  • Virus-Specific T-Cell
  • Regulatory T-Cell
  • Source of Cell
  • Bone Marrow / Matrix
  • Adipose Tissue
  • Peripheral Blood
  • Umbilical Cord
  • Placenta
  • Others
  • Target Indication
  • Infectious Diseases
  • Chronic Heart Failure
  • Crohn’s Disease
  • Ischemic Stroke
  • Hematological Cancer
  • Bone Diseases
  • Critical Limb Ischemia
  • Graft versus Host Disease
  • Duchenne Muscular Dystrophy
  • Epidermolysis Bullosa
  • Diabetic Foot Ulcer
  • Others
  • Therapeutic Area
  • Post-Transplant Infections
  • Cardiovascular Disorders
  • Autoimmune / Inflammatory Disorders
  • Cerebrovascular Disorders
  • Oncological Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Genetic Disorders
  • Others
  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific and Rest of the World

Key companies (based on the number of allogeneic cell therapies being developed; arranged in alphabetical order) covered in the report

  • Artiva Biotherapeutics
  • Allogene Therapeutics
  • Celularity
  • Cellenkos
  • Cell2Cure
  • CHABiotech
  • CRISPR Therapeutics
  • Fate Therapeutics
  • Fundamenta Therapeutics
  • GC Cell
  • Mesoblast
  • Nanjing Bioheng Biotech
  • Stemedica Cell Technologies

To view more details on this report, click on the link

News article

Blockchain in Drug Discovery and Clinical Trials Market

Learn from experts:  do you know about these emerging industry trends?

Top 10 Companies Offering Oral Solid Dosage Manufacturing Services

Top 10 Quantum Computing Companies Transforming Drug Discovery

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects


Ben Johnson

+1 (415) 800 3415

[email protected]a

Leave a Reply

Your email address will not be published. Required fields are marked *